Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Carefirst Caremark / Anzemet Dolasetron Mesylate

Anzemet Dolasetron Mesylate — Carefirst Caremark

4 indications indexed for this drug.

Hyperemesis Gravidarum
View coverage criteria
Moderately To Highly Emetogenic Chemotherapy
View coverage criteria
Radiation Therapy
View coverage criteria
Radiation Therapy Or Moderate To Highly Emetogenic Chemother
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.